Ronald Surowitz
Family Medicine · Jupiter, FLNPI 1679656656
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by AbbVie at 41.6% of the total. Reporting peaked in 2022 at $2,812 and has fallen 98.9% since, to $31 in 2025. Among family medicine clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $77.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Regeneron$1K
- AstraZeneca$519
- Novo Nordisk$415
- Modernatx, Inc.$225
- Nevro Corp.$205
- plus $1K from 17 others
Across 10,153 payments — averaging $3774.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$15.6M
- Janssen Research & Development, LLC$11.2M
- Pfizer$2.4M
- GSK$1.6M
- Boehringer Ingelheim International GmbH$1.4M
- Seqirus USA Inc$1.3M
- plus $4.7M from 24 others
Across 2 payments — averaging $10,500 each. An ownership or investment interest held by the physician or an immediate family member.
- Atlas Spine, Inc.$21K
What the payments were for
- Consulting fees$1,08018%
- Speaking & faculty fees$2,25038%
- Travel & lodging$2254%
- Food & beverage$2,33440%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $2,451 |
| Regeneron | 1 | $1,080 |
| AstraZeneca | 7 | $519 |
| Novo Nordisk | 31 | $415 |
| Modernatx, Inc. | 1 | $225 |
| Nevro Corp. | 2 | $205 |
| Optinose US, Inc. | 3 | $153 |
| Amarin Pharma, Inc. | 3 | $132 |
| Cardiovascular Systems Inc. | 1 | $129 |
| Abbott | 1 | $120 |
| Bayer | 1 | $108 |
| Conmed Corporation | 1 | $67 |
| GSK | 3 | $66 |
| Pfizer | 3 | $40 |
| Antares Pharma, Inc. | 2 | $40 |
| Merck | 1 | $34 |
| Amgen | 2 | $31 |
| Boehringer Ingelheim | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Kvk-tech, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,896 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Jupiter
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.